Kia ora, We are embarking on an unprecedented journey over the coming weeks in our duty to keep New Zealand safe. Our priority is the health and welfare of everyone, and that has been our immediate focus as events have unfolded rapidly.
We are in unprecedented times. Right across UniServices, we have been monitoring the situation closely and working on the best possible solutions and outcomes.
University of Auckland and Chongqing Medical University completes first clinical trial into maternal and infant nutrition in China
New Zealand’s expertise in maternal and infant health research has led to the University of Auckland’s Liggins Institute and its research transfer company, Auckland UniServices, completing its first clinical trial, the CLIMB study, in collaboratio
UniServices is an integral part of the University of Auckland's innovation and entrepreneurial ecosystem, supporting women in startup businesses.
A network of TB researchers across NZ are working with UniServices to create a NZ-wide TB Research Consortium to join with TB Alliance and other global partners to develop future TB drugs.
IP Group plc, UniServices’ UoA Inventors Fund and Matū Fund have together invested in another spin-out from the Auckland Bioengineering Institute.
Sensor Holdings Limited has purchased Auckland Bioengineering Institute spin-out StretchSense Limited, of which UniServices was shareholder.
A significant Memorandum of Understanding (MOU) signed in Japan will be of great benefit to New Zealand entrepreneurs and researchers.
UniServices Executive Director Commercialisation Will Charles was awarded the MinterEllisonRuddWatts Commercialisation Professional award at this year's Kiwinet Awards.
Funding to connect our top researchers with budding innovators is the latest milestone in the Government’s plan to boost research and development, create more high value jobs and diversify our economy, says Minister of Research, Science and Innova
Surgical Design Studio (SDS), a provider of innovative products for gastrointestinal diseases, today announces its medical devices have been granted Breakthrough Device designation by the United States Food and Drug Administration (FDA).
Professor Freshwater brings considerable global experience in the higher education sector.
Twelve outstanding finalists have been selected for the seventh annual KiwiNet Research Commercialisation Awards, designed to celebrate impact from science through successful research commercialisation within New Zealand
New Zealand universities and research institutions are a ‘hot-bed’ of entrepreneurial talent. Innovative sci-tech ideas are coming through so fast that a student-led investment committee programme is expanding nationally to cope with demand.
New University of Auckland research has examined whether Kiwi families are meeting national food and nutrition guidelines when feeding their babies.
Teachers in West Auckland will have easier access to specialist training to help struggling readers once Colwill School’s Reading Recovery Subcentre opens today.
A cell-sorting startup with considerable significance for the trillion-dollar global livestock market has been bought by a global corporate that already has significant existing operations in New Zealand.
World-leading health research and cutting edge medical innovations from the University of Auckland were showcased at a special medical technology and health commercialisation conference co-hosted by UniServices in HEDA this month.
Each year UniServices celebrates the impact of world-leading research on society by awarding the Commercialisation Medal to individual researchers and teams who have consistently excelled at delivering the societal and/or economic benefits of rese
UniServices has followed Mercedes Benz’s investment into Soul Machines with its own commitment of US$2m to a US$15m+ funding round announced recently by the company. UniServices, which owns 15% of the company, made the investment through its $20m
Artificial intelligence trailblazer Associate Professor Mark Sagar is among six New Zealanders who will receive 2018 Kea World Class New Zealand (WCNZ) Awards at a Gala Dinner in Auckland on 21st June.
An innovative University of Auckland trial using text messages has proven a success in getting people to manage their diabetes better.
Rain Therapeutics Closes US$18 Million Financing to Support Cancer Therapy Developed at the University of Auckland
Rain Therapeutics Inc., a privately-held, clinical stage biotechnology company focused on biomarker-driven, small molecule therapeutics for patients with cancer, today announced the closing of a tranched Series A financing of US$18.4 million (NZ$
Growing Up in New Zealand has warmly welcomed today’s announcement from the Minister for Social Development, the Honourable Carmel Sepuloni, that will restore funding of more than $1.9 million to the child development study.
The University of Auckland is further championing student innovation and entrepreneurship through the initiation of a brand new incubator – VentureLab. This unprecedented initiative, delivered by t
A world-leading ‘life-like’ surgical training programme, created by researchers at the University of Auckland, has been so successful it will be expanded across all district health boards (DHBs) thi
Following the University of Auckland’s recent review of its research and commercialisation functions, UniServices Limited has strengthened its support for developing IP and start-up companies and re
Government-backed Medical Research Commercialisation Fund makes first New Zealand investment in pharmaceutical company spun-out of the University of Auckland.
A culturally-adapted parenting programme for Māori families has increased parents’ confidence, reduced conflict between partners and improved children’s behaviour.
Winners of the fifth annual KiwiNet Research Commercialisation Awards, designed to celebrate commercialisation success within New Zealand’s universities and Crown Research Institutes, have been announced.
UniServices has signed a multi-million-dollar deal that will allow a significant increase in the number and quality of world class “disruptive” companies spun out of the university’s research and development.
The University of Auckland’s new Innovation Institute China (UAIIC) will provide unprecedented access to an extensive range of networks, research and funding opportunities in China.
UniServices and the University of Auckland are partnering with an American drug development company to launch a biotech start-up that will research novel cancer vaccines.